Muneer H. Abidi
- Hematology top 0.5%
- Oncology top 2%
- Molecular Biology top 10%
- Pathology and Forensic Medicine top 2%
- Genetics top 5%
- Co-authors
- Brian G.M. DurieBart BarlogieRobert Z. OrlowskiAngela DispenzieriAntje HoeringRachael SextonStephen P. KahanicJoshua Epstein
- Topics
- Multiple Myeloma Research and Treatments (32 papers)Hematopoietic Stem Cell Transplantation (31 papers)Protein Degradation and Inhibitors (13 papers)
- Journals
- The LancetJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesPolandHungary
In The Last Decade
Muneer H. Abidi
89 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Hematology 1.5k
- Oncology 1.5k
- Molecular Biology 977
- Pathology and Forensic Medicine 691
- Genetics 321
Countries citing papers authored by Muneer H. Abidi
This map shows the geographic impact of Muneer H. Abidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muneer H. Abidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muneer H. Abidi more than expected).
Fields of papers citing papers by Muneer H. Abidi
This network shows the impact of papers produced by Muneer H. Abidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muneer H. Abidi. The network helps show where Muneer H. Abidi may publish in the future.
Co-authorship network of co-authors of Muneer H. Abidi
This figure shows the co-authorship network connecting the top 25 collaborators of Muneer H. Abidi. A scholar is included among the top collaborators of Muneer H. Abidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muneer H. Abidi. Muneer H. Abidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 17 | |
| 4 | Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trialbreakdown → | 594 |
| 5 | Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trialbreakdown → | 477 |
| 6 | 38 | |
| 7 | 42 | |
| 8 | 12 | |
| 9 | 32 | |
| 10 | 20 | |
| 11 | 17 | |
| 12 | 16 | |
| 13 | 3 | |
| 14 | 24 | |
| 15 | 2 | |
| 16 | 21 | |
| 17 | 24 | |
| 18 | 9 | |
| 19 | 6 | |
| 20 | 27 |
About Muneer H. Abidi
Muneer H. Abidi is a scholar working on Hematology, Transplantation and Oncology, having authored 92 papers that have together received 2.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (32 papers), Hematopoietic Stem Cell Transplantation (31 papers) and Protein Degradation and Inhibitors (13 papers). The work is most often cited by research in Hematology (1.5k citations), Oncology (1.5k citations) and Pathology and Forensic Medicine (691 citations). Muneer H. Abidi has collaborated with scholars based in United States, Poland and Hungary. Frequent co-authors include Brian G.M. Durie, Bart Barlogie, Robert Z. Orlowski, Angela Dispenzieri, Antje Hoering, Rachael Sexton, Stephen P. Kahanic, Joshua Epstein, Christopher M. Reynolds and Frederic J. Reu. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.